Todd Sherer, PhD, is the Chief Executive Officer of The Michael J. Fox Foundation for Parkinson's Research (MJFF), reporting to the Board of Directors. Formally trained as a neuroscientist, he directs the organization's research strategy and is responsible for the Foundation's overall scientific and fundraising direction to speed treatment breakthroughs and a cure for Parkinson's disease.
Dr. Sherer has been a key architect of the Foundation's strategy to define high-priority research areas for Parkinson's disease — therapeutic targets and approaches closest or most critical to practical relevance in patients' daily lives — and leverage donor-raised capital to push projects in these areas toward the clinic. He has played a major role in efforts to increase the pharmaceutical industry's investment in Parkinson's disease drug development and to engage the patient community to encourage and expand participation in clinical research. Today he is one of the world's foremost experts on the science and business of Parkinson's drug development, speaking frequently on these topics at conferences, to the media and to members of the Parkinson's community.
Dr. Sherer's work with the Foundation began in 2003, when, as a postdoctoral fellow at Emory University in Atlanta, he was awarded MJFF funding to investigate the role of environmental factors in Parkinson's disease. He joined the Foundation's staff full time as Associate Director, Research Programs, in April 2004, and was promoted to Vice President, Research Programs, in June 2006 and Chief Program Officer in November 2010, finally assuming the role of Chief Executive Officer in May 2011.
Dr. Sherer participates in the National Academy of Science Forum on Neuroscience and Nervous System Disorders and serves on the National Center for Advancing Translational Sciences Council and the Cures Acceleration Network Review Board at the National Institutes of Health. He is also on the coordinating committee for the Morris K. Udall Centers of Excellence in Parkinson's Disease Research supported by the National Institute of Neurological Disorders and Stroke. Additionally, Dr. Sherer was selected to serve as a council member for the FasterCures' TRAIN (The Research Acceleration and Innovation Network) program.
Dr. Sherer has published more than 40 peer-reviewed articles in scientific journals and sits on the editorial board of the Journal of Parkinson's Disease. He earned his PhD in Neuroscience from the University of Virginia in Charlottesville and holds a BS in Psychology from Duke University in Durham, North Carolina.